Athersys
ATHX
#11224
Rank
A$1.19 M
Marketcap
A$0.01932
Share price
-33.50%
Change (1 day)
-98.98%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -A$62.62 Million

According to Athersys's latest financial reports the company's current earnings are A$0.08 Million. In 2022 the company made an earning of -A$0.12 Billion, an increase over its 2021 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$62.62 Million-43.18%
2022 -A$0.12 Billion-11.54%
2021 -A$0.13 Billion11.14%
2020 -A$0.12 Billion72.2%
2019 -A$65.1 Million77.29%
2018 -A$36.72 Million-22.91%
2017 -A$47.64 Million111.89%
2016 -A$22.48 Million-8.52%
2015 -A$24.58 Million-40.81%
2014 -A$41.52 Million18.62%
2013 -A$35.01 Million
2011 -A$19.73 Million19.71%
2010 -A$16.48 Million-26.28%
2009 -A$22.35 Million-18.21%
2008 -A$27.33 Million-8.28%
2007 -A$29.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.50 B-62,855.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.88 B-16,638.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.72 B-24,732.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.24 B-17,245.47%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$11.00 B-18,513.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.04 B-28,618.75%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
A$0.24 B-512.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$4.36 Billion 7,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-A$0.9 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA